Claritev Corporation Reports Fourth Quarter 2025 Results
Claritev Corporation reports financial results for the fourth quarter ended December 31, 2025 highlighting growth.

Claritev Corporation reports financial results for the fourth quarter ended December 31, 2025 highlighting growth.
Understanding the true cost of surgery is essential to improving healthcare affordability. Our analysis of six common procedures shows how full‑episode measurement—rather than single claim lines—reveals clearer insights into variability, site‑of‑care differences, and geographic trends. Better transparency leads to more meaningful opportunities to improve cost without compromising quality.
Discover how Claritev’s Chief AI Officer, Fernando Schwartz, is leveraging advanced AI to reduce healthcare’s administrative burden—streamlining claims processing, accelerating decisions, and cutting costs in an industry where bureaucracy accounts for 15–25% of total expenses.
Michael Lo Presti thought he was in the best shape of his life — until a routine physical revealed a hidden heart condition that would change everything. From ultramarathons to open-heart surgery and back to the starting line, his journey highlights the power of data-driven decisions, resilience, and living each day with urgency and gratitude.
Rural healthcare providers face unprecedented challenges as the One Big Beautiful Bill Act (OBBBA) reshapes coverage, funding, and operations. This white paper explores actionable strategies to help organizations move from reaction to resilience—leveraging data-driven decision-making and long-term planning to thrive amid policy-driven disruption.
Healthcare providers are facing mounting financial pressure driven by rising costs, complexity, and misaligned incentives. This blog explores how leveraging data and AI can bring greater transparency to pricing, uncover hidden opportunities, and enable smarter decisions that improve both financial performance and patient engagement.
Claritev will release its Q2 2025 financial results on August 6, at 8:00 AM ET. Gain valuable insights into our vision to drive affordability in healthcare. Pre-register now for access to the call.
In this white paper, Claritev’s comprehensive surgical cost analysis provides insights to help understand and optimize healthcare expenditure through a data-driven approach.
Struggling with managing rising GLP-1 drug costs? Every company's cost drivers are different, making a one-size-fits-all approach ineffective. Learn how data-driven insights can help employers balance coverage and costs while optimizing member outcomes.
As a part of Claritev’s Payment Integrity service, we review claims to ensure there are no billing errors and that the charges make sense. When we find mistakes or suspicious charges, we investigate. This blog details findings that left us shaking our heads.